Latest News about AZN
Recent news which mentions AZN
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
From Benzinga
AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting
August 08, 2022
From Benzinga
3 Unstoppable Stocks That Don't Care About the Bear Market
August 07, 2022
From Motley Fool
From MarketWatch
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 04, 2022
From Benzinga
From Benzinga
AstraZeneca and Merck Receives European Commission Approval For Expanded Use In Breast Cancer Therapy
August 04, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
From Benzinga
From Benzinga
From Motley Fool
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance
July 29, 2022
From Benzinga
Earnings Scheduled For July 29, 2022
July 29, 2022
From Benzinga
FDA Accepts AstraZeneca's Submission For Low Breast Cancer Candidate Under Priority Review
July 25, 2022
Tickers
AZN
From Benzinga
From Benzinga
U.S. Stock Futures Higher; Crude Oil Rises 1%
July 25, 2022
From Benzinga
Europe's CHMP Recommends Approving AstraZeneca's Asthma, Neuromuscular Disorder Treatments
July 25, 2022
From Benzinga
Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earning Picks Up Pace
July 24, 2022
From Benzinga
From Motley Fool
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.